These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15747987)

  • 41. [Oral diabetic treatment is no longer enough. Making a successful transition to insulin therapy (interview by Dr. Judith Neumaier)].
    Fritsche A
    MMW Fortschr Med; 2004 May; 146(21):60. PubMed ID: 15373090
    [No Abstract]   [Full Text] [Related]  

  • 42. How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?
    Koenen C
    Nat Clin Pract Endocrinol Metab; 2008 Oct; 4(10):E1. PubMed ID: 18806804
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes: response to Nathan et al.
    Eizirik DL
    Diabetes Care; 2009 Mar; 32(3):e35-6; author reply e37-8. PubMed ID: 19246586
    [No Abstract]   [Full Text] [Related]  

  • 44. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J; Nadeau DA
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
    Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
    Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical perspectives in type 2 diabetes care: optimizing glycemic control with insulin therapy.
    Diabetes Educ; 2005; Suppl():1-14; quiz 15-6. PubMed ID: 15786628
    [No Abstract]   [Full Text] [Related]  

  • 47. [Inhibition of platelet aggregation].
    Wascher TC
    Acta Med Austriaca; 2004; 31(5):170. PubMed ID: 15747991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
    Malesker MA
    Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diabetes therapy in pregnant women].
    Zárate A; Hernández Valencia M; Basurto L; Saucedo R
    Ginecol Obstet Mex; 2008 Apr; 76(4):211-6. PubMed ID: 18798420
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Good practice and update in oral antidiabetic agents].
    Vandemergel X
    Rev Med Brux; 2010 Sep; 31(4):371-6. PubMed ID: 21089417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Type 2 diabetes mellitus and Aboriginal Australians. Options for oral therapy in the control of glyceamia.
    Bell D
    Aust Fam Physician; 1998 Nov; 27(11):1017-20. PubMed ID: 9845993
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Treatment of diabetes mellitus with oral antidiabetic agents].
    Bruns W
    Z Arztl Fortbild (Jena); 1988; 82(17):805-9. PubMed ID: 3062917
    [No Abstract]   [Full Text] [Related]  

  • 53. [Differential therapy with oral antidiabetic drugs].
    Mehnert H
    Med Klin (Munich); 1991 Oct; 86(10):521-5. PubMed ID: 1758375
    [No Abstract]   [Full Text] [Related]  

  • 54. Extent of glycemic control in type 2 diabetes mellitus: close, but no cigar.
    Lerch C; Richter B
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):593-5. PubMed ID: 19833492
    [No Abstract]   [Full Text] [Related]  

  • 55. [Insulin therapy of diabetes].
    Lechleitner M; Roden M; Weitgasser R; Ludvik B; Fasching P; Hoppichler F; Kautzky-Willer A; Schernthaner G; Prager R; Wascher TC
    Wien Klin Wochenschr; 2012 Dec; 124 Suppl 2():17-22. PubMed ID: 23250454
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Management of home monitoring of glycemia in public pharmacies].
    Duquet N;
    J Pharm Belg; 2009 Dec; (4):115-8. PubMed ID: 20183987
    [No Abstract]   [Full Text] [Related]  

  • 57. Oral hypoglycemics in cats with diabetes mellitus.
    Palm CA; Feldman EC
    Vet Clin North Am Small Anim Pract; 2013 Mar; 43(2):407-15. PubMed ID: 23522179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Adverse effects of oral hypoglycemic drugs in elderly patients].
    Zakowska-Wachelko B
    Pol Tyg Lek; 1990 May 7-14; 45(19-20):389-91. PubMed ID: 2255657
    [No Abstract]   [Full Text] [Related]  

  • 59. [New oral antidiabetic glitazones].
    Johansen K
    Ugeskr Laeger; 2001 Dec; 164(1):76-7. PubMed ID: 11810811
    [No Abstract]   [Full Text] [Related]  

  • 60. American Diabetes Association. Resource guide 2005. Class action: type 2 pills update.
    McCarren M
    Diabetes Forecast; 2005 Jan; 58(1):RG6-9. PubMed ID: 15714615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.